期刊文献+

某院近五年多重耐药菌分布及耐药性分析 被引量:5

Analysis of distribution and drug resistance of multidrug-resistant organisms
下载PDF
导出
摘要 目的了解医院感染多重耐药菌(MDROs)的分布特征及耐药性。方法回顾性分析2010~2014年该院分离的MDROs分布特征及耐药性,按国际标准化建议的共识方法对不同MDROs进行定义;采用WHONET5.6软件进行数据统计处理。结果 2010~2014年共分离MDROs 5 709株,其中葡萄球菌2 441株(42.76%),非发酵菌2 091株(36.63%),肠球菌737株(12.90%),肠杆菌科细菌440株(7.71%)。5 709株MDROs主要来自呼吸道标本(55.04%)。多重耐药大肠埃希菌和肺炎克雷伯菌对头孢哌酮/舒巴坦、亚胺培南、美罗培南的耐药率小于30%;多重耐药鲍曼不动杆菌对米诺环素、头孢哌酮/舒巴坦的耐药率为20.2%、50.6%,对其余抗菌药物的耐药率均超过90%;除多黏菌素B外,多重耐药铜绿假单胞菌对其余抗菌药物的耐药率为71.4%~97.0%;多重耐药屎肠球菌对米诺环素的耐药率为13.8%,对利奈唑胺、替考拉宁、万古霉素的耐药率小于3%,对其余抗菌药物的耐药率均超过90%。1 914株耐甲氧西林金黄色葡萄球菌(MRSA)中检出1株利奈唑胺耐药菌株,未检出万古霉素、替考拉宁耐药菌株。结论该院MDROs主要以鲍曼不动杆菌和MRSA占优势,应加强医院感染监测和采取有效的感染控制措施,以防止MDROs播散。 Objective To investigate the distribution and antimicrobial resistance of multidrug-resistant organisms(MDROs).Methods The distribution and antimicrobial resistance of MDROs,isolated from 2010 to 2014,were retrospectively analyzed.MDROs were identified according to international consensus.The WHONET5.6software was used to analyze data.Results A total of 5 709 strains of MDROs were isolated in five years,in which 2 441 strains were Staphylococcus(42.76%),2 091 strains were non-fermentive bacterial(36.63%),737 strains were Enterococcus(12.90%),440 strains were Enterobacter(7.71%).Of the 5 709 MDROs isolates,55.04% were isolated from respiratory tract specimens.The resistant rate of multidrug-resistant E.coli and K.pneumoniae against cefoperazone/sulbactam,imipenem and meropenem was less than 30%.The resistance of multidrug-resistant A.baumanii was higher than 90%,except to minocycline and cefoperazone/sulbactam,20.2% and 50.6% respectively.The resistant rate of multidrug-resistant P.aeruginosa was 71.4%-97.0%against other antimicrobial agents,except to polymyxin B.The resistance of multidrug-resistant E.faecium against the antimicrobials was higher than 90%,except 13.8% to minocycline and less than 3%to linezolid,teicoplanin and vancomycin.Meanwhile,1 linezolid resistant strain was identified in 1 914 methicillin resistant S.aureus(MRSA)strains and all MRSA strains were susceptible to vancomycin and teicoplanin.Conclusion MDROs could be predominated by A.bauman and MRSA in this hospital.Monitoring and control measures to healthcare-associated infections should be intensified to prevent the spread of MDROs.
出处 《国际检验医学杂志》 CAS 2015年第21期3098-3100,共3页 International Journal of Laboratory Medicine
关键词 多药耐药菌 耐药性 抗菌药物 multidrug-resistant organisms drug resistance antibacterials
  • 相关文献

参考文献15

二级参考文献32

  • 1俞森洋.常见感染致病菌的耐药机制及防治对策[J].中国呼吸与危重监护杂志,2002,1(2):71-75. 被引量:19
  • 2王东浩,王伟,王勇强,曹书华.重症监护病房获得性细菌感染临床调查[J].中华医院感染学杂志,2004,14(2):151-153. 被引量:127
  • 3戚其学,王春雷,李艳玲.169例非发酵革兰阴性杆菌所致院内获得性肺炎的危险因素及耐药性分析[J].中国血液流变学杂志,2007,17(2):290-292. 被引量:19
  • 4McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria:multidrug resistance to the maximum. Am J Med, 2006, 119 : S29 -S36.
  • 5Quinn JP. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis, 1998,27 : S117-S124.
  • 6Tenover FC. Novel and emerging mechanisms of antimicrobial resistance in nosoeomial pathogens. Am J Med, 1991,91 : 76 S-81 S.
  • 7Smith SM, Eng RK, Teeson-Tumany F. Ciprofloxaein therapy for methieillin-resistant Staphylococcus aureus infections or colonizations. Antimicrob Agents Chemother,1989,33:181-184.
  • 8Du B, Chen D, Liu D, et al. Restriction of third-generation eephalosporin use decreases infection-related mortality. Crit Care Med,2003,31:1088-1093.
  • 9Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-laetamases at a Massachusetts chronic-care facility. Antimierob Agents Chemother, 1990,34:2193-2199.
  • 10Wallace MR, Johnson AP, Daniel M, et al. Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain. J Hosp Infect, 1995,31:247-252.

共引文献498

同被引文献40

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部